Chappell S E, Wolfson M R, Shaffer T H
Department of Physiology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA.
Respir Med. 2001 Jul;95(7):612-7. doi: 10.1053/rmed.2001.1114.
The objective of this study was to compare surfactant (SF) distribution and physiological effects after standard SF delivery during conventional mechanical ventilation (CMV) with that using partial liquid ventilation (PLV). A model of meconium aspiration syndrome (MAS) was developed using two groups of adult rats (n = 14). After meconium instillation of 2.5 ml kg(-1) (20% v/w), SF/CMV: (n = 7) CMV and SF/PLV: (n = 7) PLV, received 14C-labeled surfactant (4 ml kg(-1)) delivered intratracheally in four aliquots over 20 min in both groups. Sequential measurements of arterial blood chemistry and lung mechanics were performed in all animals. At the conclusion of experiments, lungs were inflated (30 cmH2O), dried, sectioned and evaluated for radioactivity in disintegrations per minute (DPM). Surfactant distribution was improved (P< 0.01) with PLV as compared to CMV with 48.8% of the pieces vs. 30.9% of the pieces receiving within 25% of the mean amount of surfactant, respectively. Further, regional distribution was also significantly more uniform with PLV than CMV: left vs right (P<0.01) lung and ventral vs. dorsal (P<0.01) regions. Finally, arterial PO2 and ventilation efficiency index were significantly (P<0.01) greater post-treatment in SF/PLV than SF/CMV. These data demonstrate surfactant delivery with PLV, as compared to CMV alone, to be an improved method of delivering surfactant in MAS and suggest the possible utility of SF/PLV combination therapy for its treatment of other etiologies of neonatal respiratory distress.
本研究的目的是比较在传统机械通气(CMV)期间标准表面活性剂(SF)给药后与使用部分液体通气(PLV)时SF的分布及生理效应。使用两组成年大鼠(n = 14)建立胎粪吸入综合征(MAS)模型。在注入2.5 ml kg⁻¹(20% v/w)胎粪后,SF/CMV组(n = 7)进行CMV,SF/PLV组(n = 7)进行PLV,两组均在20分钟内分四次经气管内给予14C标记的表面活性剂(4 ml kg⁻¹)。对所有动物进行动脉血液化学和肺力学的连续测量。实验结束时,将肺充气(30 cmH₂O)、干燥、切片,并评估每分钟的放射性衰变计数(DPM)。与CMV相比,PLV使表面活性剂分布得到改善(P<0.01),分别有48.8%的肺组织与30.9%的肺组织接受的表面活性剂剂量在平均剂量的25%以内。此外,PLV组的区域分布也比CMV组明显更均匀:左肺与右肺(P<0.01)以及腹侧与背侧区域(P<0.01)。最后,SF/PLV组治疗后的动脉血氧分压和通气效率指数显著高于SF/CMV组(P<0.01)。这些数据表明,与单独的CMV相比,PLV给药是在MAS中递送表面活性剂的一种改进方法,并提示SF/PLV联合疗法在治疗新生儿呼吸窘迫其他病因方面可能具有实用性。